New research highlighted how aspirin is unnecessary in antithrombotic regimens for patients with advanced heart failure and fully magnetically levitated left ventricular assist devices (LVADs). Among ...

Aspirin alone after transcatheter aortic valve implantation (TAVI) significantly reduced bleeding compared with aspirin plus clopidogrel, without increasing thromboembolic events, in the latest ...

A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.

The ARIES-HM3 Randomized Clinical Trial assessed the safety and efficacy of excluding aspirin from the antithrombotic regimen in patients with advanced heart failure who have undergone implantation of ...

Please provide your email address to receive an email when new articles are posted on . A dual antithrombotic therapy regimen consisting of a non-vitamin K antagonist oral anticoagulant and a P2Y12 ...

Among patients with A-fib who are treated for ACS or undergo elective PCI, it’s possible that some will benefit from up to 30 days of aspirin on top of a P2Y12 inhibitor and oral anticoagulant, post ...

A new state-of-the-art consensus statement from a group of American and European experts highlights the currently recommended antithrombotic treatment strategies for patients with atrial fibrillation ...

Please provide your email address to receive an email when new articles are posted on . Many patients undergoing transcatheter aortic valve replacement have multiple thrombotic and bleeding-related ...

Antithrombotic therapy in clinically stable, nonhospitalized COVID-19 patients does not offer protection against adverse cardiovascular or pulmonary events, new randomized clinical trial results ...

April 1 -- Aspirin has been a pain-reliever for more than 100 years. And while most of the popular remedies used in the 19th century have been abandoned, the use of aspirin has increased. This ...